CSCs, a subpopulation of cells, are characterized by some key markers, such as CD133, CD166, CD44, CD24, SOX2, OCT4, and ALDH, which are associated with tumor initiation, growth, and therapy resistance [17]. This evidence concerns the gene CD24 and neoplasm.